References
Woodcock JW, Dohm J. Toward better-quality compounded drugs—an update from the FDA. N Engl J Med. 2017;377(26):2509–12.
Sigillito RJ, Tuckler VE, Van Meter KW, Martinez J. Near fatal accidental transdermal overdose of compounded ketamine, baclofen, amitriptyline, lidocaine and ketoprofen: a case report. J Toxicol Clin Toxicol. 2003;41(5):672.
Sullivan RW, Ryzewski M, Holland MG, Marraffa JM. Compounded ointment results in severe toxicity in a pediatric patient. Pediatr Emer Care. 2013;29:1220–2.
Pomerleau AC, Gooden CE, Fantz CR, Morgan BW. Dermal exposure to a compounded pain cream resulting in severely elevated clonidine concentration. J Med Toxicol. 2014;10(1):61–4.
Lucyk SN, Nelson LS, Hoffman RS, Howland MA, Su M. Ingestion of compounded ointment leading to significant toxicity in a child. Clin Toxicol. 2014;52(7):801.
Henretig F, Trella J, Osterhoudt K. Toxicity from compounded analgesic creams. Clin Toxicol. 2014;52(7):801–2.
Swartzentruber GS, Raja AH, Menke NB, Lynch MJ. Inappropriate application of compounded topical pain medication cream leading to significant neurotoxicity. Clin Toxicol. 2014;52(7):692–3.
Lange R, LeRoy JM, Cole J. Apnea in a child following dermal exposure to compounded pain cream. Clin Toxicol. 2017;55(7):733.
Ellison C, Lyndon S. Staying topical an unusual case of serotonin syndrome. J Clin Psychopharmacol. 2017;37(5):633–5.
Soumoff AA, Cook DL, Clark CC. Delirium following topical application of compounded creams containing multiple analgesic medications in geriatric patients: two new cases. Psychosomatics. 2018;59:81–9.
Cates A, Wheatley S, Katz K. Clonidine overdose in a toddler due to accidental ingestion of a compounding cream. Pediatr Emerg Care 2018;34(4):e79-81.
Cardis MS, Pasieka HB. Safety of topical neuromodulators for the treatment of pruritus. JAMA Dermatol. 2016;152(12):1390–1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors, Jenny Kim, Karen Konkel, S. Christopher Jones, and Lynda McCulley, do not have any potential conflicts of interest to disclose.
Funding
No sources of funding were used to assist in the preparation of this study.
Data Sharing
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Rights and permissions
About this article
Cite this article
Kim, J., Konkel, K., Jones, S.C. et al. Systemic Adverse Events Associated with Compounded Topical Pain Products. Drug Saf 43, 497–501 (2020). https://doi.org/10.1007/s40264-020-00927-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-020-00927-2